Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesKynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsThe physiological action of picolinic Acid in the human brainCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisPathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic ReviewKynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyGlia in the cytokine-mediated onset of depression: fine tuning the immune responseQuinolinic acid, the inescapable neurotoxinCytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaiseEmerging roles of pericytes in the regulation of the neurovascular unit in health and diseaseToxoplasma gondii-induced neuronal alterationsCharacterisation of the expression of NMDA receptors in human astrocytesPsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorNeuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stressThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyIndoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampusThe pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in miceInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorNeurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.The excitotoxin quinolinic acid induces tau phosphorylation in human neuronsKynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia.Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-GuerinThe Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depressionDifferential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat proteinMicroglial Activation in the Pathogenesis of Huntington's Disease.Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cellsCentral administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice culturesNeuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons.Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase.The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.Kynurenines: from the perspective of major psychiatric disorders.M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.The kynurenine pathway is involved in bacterial meningitis.Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharideLead dysregulates serine/threonine protein phosphatases in human neurons.Kynurenine pathway metabolites in humans: disease and healthy States.
P2860
Q21129356-26FDDC95-BF9D-46F7-A9ED-BAFD37B73C28Q24623659-2817420E-EE2B-44AA-AA18-5921BAD4BADFQ24634995-FAE19F44-EDA8-49AE-A7AF-13C21CF7183EQ26740330-C19F97C8-EEC0-4EED-A016-989F946E4A2CQ26749017-C02EE7F5-51C0-497E-87EC-2B17BBDFC90BQ26782867-9C34715B-C22B-4E4F-B70D-6E2BA27DE4D0Q26798929-E15F1B1C-440B-4FEE-AB2E-98A7173494E0Q26991715-3E0479DE-75BC-436E-BA12-686D451E78A4Q27001628-DA13AD8B-9C1B-49D5-9013-0349DF72C01CQ27011505-F8E4346D-8136-4B98-B2EE-4350E2052992Q27027025-B8B26115-EA4D-4CE4-BF05-72429E6912B7Q27316321-DC9864BB-1421-49A4-979F-F178D7D84931Q27694728-516887A1-E072-42D5-B4B7-6E861DC16509Q28069771-82369741-90DE-4452-A396-6610F838E7B4Q28073631-0FC35329-A306-4DFA-8D98-E177F214D4B4Q28260918-56000A9D-6B8C-40F7-ADFD-6FE79E756F48Q28485282-F47F380B-85D3-4433-AC7F-8F39750496BFQ28508390-913177CE-0998-4465-B030-772F709B32ACQ30839124-40755271-C6B2-45EB-95E7-358A16C0C573Q33310422-799DD17D-5508-4E21-8E05-5A2D40A4CAE8Q33485236-3A5DAA0D-22F3-431D-B37F-4106214F0C84Q33572850-188E8070-A50E-4AAD-8BCD-95847486DCDCQ33635999-825FEE77-EB1A-4553-B340-223934423C1AQ33715452-78824892-C52B-483D-B2AB-72B9CCE81658Q33737263-7FA8D674-2F84-4EBA-BFB9-567534C355C4Q33751166-3A4D044F-9CE5-4938-8157-DDE0AFF28383Q33786188-44AEFD77-4299-4D5C-8E54-0DB5E46F7591Q33809556-DD4829E4-8490-43CB-91F2-40C57C1F121CQ34012783-01AB034B-555B-47D8-B151-AD4D7D78BCC3Q34014666-D5C1E509-4D13-4875-AD53-F9EABCFEC3DFQ34064890-F850CD4B-5A70-4687-96E1-C4B90EF93BBEQ34088466-6D1486EA-144A-4E1A-8277-289F3A1DAB2DQ34168670-B300E71C-A244-4538-BE81-376ABE7A9C91Q34248380-AFDFD114-ED54-4A6D-9EA6-2D280158F514Q34260092-FF5F38F2-0652-4FA6-B873-9F326D864EC0Q34287451-8BB1A0E0-E690-4006-AA70-9FD902A05635Q34306405-381E7950-E6B2-4C13-BC06-1DDD71071429Q34478106-E42EC1CE-DC13-4F44-AC98-5E356942826CQ34500924-000B1A5A-81CF-408F-8C2C-C5133B41E0C7Q34633683-8ED3EABF-161E-4B3C-AADC-52527DADFF64
P2860
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@ast
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@en
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@nl
type
label
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@ast
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@en
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@nl
prefLabel
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@ast
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@en
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@nl
P2093
P356
P1433
P1476
Expression of indoleamine 2,3- ...... glia, astrocytes, and neurons.
@en
P2093
Bruce J Brew
George Smythe
Gilles J Guillemin
Osamu Takikawa
P2860
P356
10.1002/GLIA.20090
P577
2005-01-01T00:00:00Z